Expression patterns of CD44 and CD44 splice variants in patients with rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 30, Issue 1, 2012, Pages 64-72

  Grisar, Johannes ^a   Munk, Marion ^a   Steiner, Carl W ^a   Amoyo Minar, Love ^a   Tohidast Akrad, Makiyeh ^b   Zenz, Peter ^c   Steiner, Günter ^a,b   Smolen, Josef S ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c Orthopaedic Centre   (Austria)

Author keywords

CD44; Monocytes; Rheumatoid arthritis; Splice variants; Synovium

Indexed keywords

C REACTIVE PROTEIN; CD44V ANTIGEN; CD44V10 ANTIGEN; CD44V3 ANTIGEN; CD44V4 ANTIGEN; CD44V5 ANTIGEN; CD44V6 ANTIGEN; CD44V7 ANTIGEN; CD44V8 ANTIGEN; CD44V9 ANTIGEN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERLEUKIN 1BETA; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL LINEAGE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MONOCYTE; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM;

ANTIGENS, CD44; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; HUMANS; INTERLEUKIN-1BETA; MIDDLE AGED; MONOCYTES; OSTEOARTHRITIS; PROTEIN ISOFORMS; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863752699     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. SMOLEN JS, STEINER G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2003; 2: 473-88.
2. SMOLEN JS, ALETAHA D, KOELLER M, WEISMAN MH, EMERY P. New therapies for treatment of rheumatoid arthritis. Lancet 2007; 370: 1861-74.
3. NAGANO O, SAYA H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95: 930-5.
4. KITTL EM, HABERHAUER G, RUCKSER R et al. Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis. Rheumatol Int 1997; 16: 181-6.
5. MIKECZ K, BRENNAN FR, KIM JH, GLANT TT. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med 1995; 1: 558-63.
6. MIKECZ K, DENNIS K, SHI M, KIM JH. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum 1999; 42: 659-68.
7. hwgoc-bcpgCsCas. In.
8. SKOTHEIM RI, NEES M. Alternative splicing in cancer: noise, functional, or systematic? Int J Biochem Cell Biol 2007; 39: 1432-49.
9. HERRERA-GAYOL A, JOTHY S. Adhesion proteins in the biology of breast cancer: contribution of CD44. Exp Mol Pathol 1999; 66: 149-56.
10. WIBULSWAS A, CROFT D, PITSILLIDES AA et al. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints. Arthritis Rheum 2002; 46: 2059-64.
11. TOLBOOM TC, HUIDEKOPER AL, KRAMER IM, PIETERMAN E, TOES RE, HUIZINGA TW. Correlation between expression of CD44 splice variant v8-v9 and invasiveness of fibroblast-like synoviocytes in an in vitro system. Clin Exp Rheumatol 2004; 22: 158-64.
12. FUCHS S, ROLAUFFS B, ARNDT S, TIBESKU CO, PREHM P. CD44H and the isoforms CD44v5 and CD44v6 in the synovial fluid of the osteoarthritic human knee joint. Osteoarthritis Cartilage 2003; 11: 839-44.
13. TIBESKU CO, SZUWART T, OCKEN SA, SKWARA A, FUCHS S. Increase in the expression of the transmembrane surface receptor CD44v6 on chondrocytes in animals with osteoarthritis. Arthritis Rheum 2005; 52: 810-7.
14. KIENER HP, WATTS GF, CUI Y et al. Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in threedimensional organ culture. Arthritis Rheum 2010; 62: 742-52.
15. REDLICH K, HAYER S, RICCI R et al. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest 2002; 110: 1419-27.
16. GOLDRING SR, GRAVALLESE EM. Pathogenesis of bone lesions in rheumatoid arthritis. Curr Rheumatol Rep 2002; 4: 226-31.
17. HAYER S, STEINER G, GORTZ B et al. CD44 is a determinant of inflammatory bone loss. J Exp Med 2005; 201: 903-14.
18. NAOR D, NEDVETZKI S. CD44 in rheumatoid arthritis. Arthritis Res Ther 2003; 5: 105-15.
19. ALETAHA D, NELL VP, STAMM T et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: R796-806.
20. ARNETT FC, EDWORTHY SM, BLOCH DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
21. SCHETT G, TOHIDAST-AKRAD M, SMOLEN JS et al. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogenactivated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 2000; 43: 2501-12.
22. CROTTI TN, SMITH MD, WEEDON H et al. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis 2002; 61: 1047-54.
23. TAK PP, VAN DER LUBBE PA, CAULI A et al. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 1995; 38: 1457-65.
24. BLAHETA RA, POWERSKI M, HUDAK L et al. Tumor-endothelium cross talk blocks recruitment of neutrophils to endothelial cells: a novel mechanism of endothelial cell anergy. Neoplasia 2009; 11: 1054-63.
25. HERRLICH P, MORRISON H, SLEEMAN J et al. CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann N Y Acad Sci 2000; 910: 106-18; discussion 118-120.
26. HAYNES BF, HALE LP, PATTON KL, MARTIN ME, MCCALLUM RM. Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum 1991; 34: 1434-43.
27. DE VRIES TJ, SCHOENMAKER T, BEERTSEN W, VAN DER NEUT R, EVERTS V. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation. J Cell Biochem 2005; 94: 954-66.
28. CRISPIN JC, KEENAN BT, FINNELL MD et al. Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity. Arthritis Rheum 2010; 62: 1431-7.
29. WIBULSWAS A, CROFT D, BACARESE-HAMILTON I, MCINTYRE P, GENOT E, KRAMER IM. The CD44v7/8 epitope as a target to restrain proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Am J Pathol 2000; 157: 2037-44.
30. MAYER S, ZUR HAUSEN A, WATERMANN DO et al. Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients. J Cancer Res Clin Oncol 2008; 134: 1229-35.
31. KAWANO T, YANOMA S, NAKAMURA Y et al. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer. Am J Otolaryngol 2005; 26: 308-13.
32. AMIRGHOFRAN Z, JALALI SA, HOSSEINI SV, VASEI M, SABAYAN B, GHADERI A. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis. J Gastrointest Cancer 2008; 39: 73-8.
33. AFIFY A, PANG L, HOWELL L. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids. Appl Immunohistochem Mol Morphol 2007; 15: 446-50.
34. HEFLER LA, CONCIN N, MINCHAM D et al. The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma: a multicenter study. Cancer 2002; 94: 125-30.
35. BAUER S, JENDRO MC, WADLE A et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther 2006; 8: R171.
36. KRETTEK A, SUKHOVA GK, SCHONBECK U, LIBBY P. Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells. Am J Pathol 2004; 165: 1571-81.
37. CAMACHO FI, MUNOZ C, SANCHEZ-VERDE L, SAEZ AI, ALCANTARA M, RODRIGUEZ R. CD44v6 expression in inflammatory bowel disease is associated with activity detected by endoscopy and pathological features. Histopathology 1999; 35: 144-9.
38. ZEN K, LIU DQ, GUO YL et al. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS One 2008; 3: e1826.
39. CROFT DR, DALL P, DAVIES D, JACKSON DG, MCINTYRE P, KRAMER IM. Complex CD44 splicing combinations in synovial fibroblasts from arthritic joints. Eur J Immunol 1997; 27: 1680-4.
40. HUBER LC, DISTLER O, TARNER I, GAY RE, GAY S, PAP T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 669-75.